Cardiff Oncology (Germany) Buy Hold or Sell Recommendation
XE7C Stock | EUR 4.18 0.13 3.21% |
Assuming the 90 days trading horizon and your way above-average risk tolerance, our recommendation regarding Cardiff Oncology is 'Strong Sell'. Macroaxis provides Cardiff Oncology buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding XE7C positions. The advice algorithm takes into account all of Cardiff Oncology's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Cardiff Oncology's buy or sell advice are summarized below:
Real Value 3.15 | Hype Value 4.05 | Market Value 4.18 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Cardiff Oncology given historical horizon and risk tolerance towards Cardiff Oncology. When Macroaxis issues a 'buy' or 'sell' recommendation for Cardiff Oncology, the advice is generated through an automated system that utilizes algorithms and statistical models.
Cardiff |
Execute Cardiff Oncology Buy or Sell Advice
The Cardiff recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cardiff Oncology. Macroaxis does not own or have any residual interests in Cardiff Oncology or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cardiff Oncology's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Solid | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Cardiff Oncology Trading Alerts and Improvement Suggestions
Cardiff Oncology is way too risky over 90 days horizon | |
Cardiff Oncology appears to be risky and price may revert if volatility continues | |
The company reported the revenue of 359 K. Net Loss for the year was (28.29 M) with loss before overhead, payroll, taxes, and interest of (17.02 M). | |
Cardiff Oncology has accumulated about 140.05 M in cash with (23.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.54. |
Cardiff Oncology Returns Distribution Density
The distribution of Cardiff Oncology's historical returns is an attempt to chart the uncertainty of Cardiff Oncology's future price movements. The chart of the probability distribution of Cardiff Oncology daily returns describes the distribution of returns around its average expected value. We use Cardiff Oncology price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cardiff Oncology returns is essential to provide solid investment advice for Cardiff Oncology.
Mean Return | 1.94 | Value At Risk | -10.27 | Potential Upside | 23.17 | Standard Deviation | 9.70 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cardiff Oncology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Cardiff Oncology Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cardiff Oncology or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cardiff Oncology's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cardiff stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 1.91 | |
β | Beta against NYSE Composite | 0.38 | |
σ | Overall volatility | 9.78 | |
Ir | Information ratio | 0.19 |
Cardiff Oncology Volatility Alert
Cardiff Oncology is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cardiff Oncology's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cardiff Oncology's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Cardiff Oncology Fundamentals Vs Peers
Comparing Cardiff Oncology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cardiff Oncology's direct or indirect competition across all of the common fundamentals between Cardiff Oncology and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cardiff Oncology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cardiff Oncology's fundamental indicators could also be used in its relative valuation, which is a method of valuing Cardiff Oncology by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Cardiff Oncology to competition |
Fundamentals | Cardiff Oncology | Peer Average |
Return On Equity | -0.32 | -0.31 |
Return On Asset | -0.19 | -0.14 |
Operating Margin | (102.39) % | (5.51) % |
Current Valuation | (45.06 M) | 16.62 B |
Shares Outstanding | 44.68 M | 571.82 M |
Shares Owned By Insiders | 7.30 % | 10.09 % |
Shares Owned By Institutions | 23.02 % | 39.21 % |
Price To Book | 0.57 X | 9.51 X |
Price To Sales | 147.11 X | 11.42 X |
Revenue | 359 K | 9.43 B |
Gross Profit | (17.02 M) | 27.38 B |
EBITDA | (27.84 M) | 3.9 B |
Net Income | (28.29 M) | 570.98 M |
Cash And Equivalents | 140.05 M | 2.7 B |
Cash Per Share | 3.54 X | 5.01 X |
Total Debt | 408 K | 5.32 B |
Debt To Equity | 0 % | 48.70 % |
Current Ratio | 31.20 X | 2.16 X |
Book Value Per Share | 2.61 X | 1.93 K |
Cash Flow From Operations | (23.04 M) | 971.22 M |
Earnings Per Share | (0.81) X | 3.12 X |
Target Price | 25.33 | |
Number Of Employees | 22 | 18.84 K |
Beta | 1.66 | -0.15 |
Market Capitalization | 77.48 M | 19.03 B |
Total Asset | 149.54 M | 29.47 B |
Net Asset | 149.54 M |
Cardiff Oncology Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cardiff . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Cardiff Oncology Buy or Sell Advice
When is the right time to buy or sell Cardiff Oncology? Buying financial instruments such as Cardiff Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cardiff Oncology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Real Estate Thematic Idea Now
Real Estate
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Real Estate theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate Theme or any other thematic opportunities.
View All Next | Launch |
Check out Cardiff Oncology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Cardiff Stock please use our How to Invest in Cardiff Oncology guide.Note that the Cardiff Oncology information on this page should be used as a complementary analysis to other Cardiff Oncology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Cardiff Stock analysis
When running Cardiff Oncology's price analysis, check to measure Cardiff Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardiff Oncology is operating at the current time. Most of Cardiff Oncology's value examination focuses on studying past and present price action to predict the probability of Cardiff Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardiff Oncology's price. Additionally, you may evaluate how the addition of Cardiff Oncology to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |